These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 26190379
1. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation. Bryce E, Grant J, Scharf S, Dempster L, Lau TT, Laing F, Shajari S, Forrester L. Am J Infect Control; 2015 Nov; 43(11):1238-43. PubMed ID: 26190379 [Abstract] [Full Text] [Related]
2. Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong. Cheng VC, Tai JW, Chen JH, So SY, Ng WC, Hung IF, Leung SS, Wong SC, Chan TC, Chan FH, Ho PL, Yuen KY. J Formos Med Assoc; 2014 Oct; 113(10):734-41. PubMed ID: 24796821 [Abstract] [Full Text] [Related]
4. Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital. Popiel KY, Miller MA. Infect Control Hosp Epidemiol; 2014 Jul; 35(7):818-25. PubMed ID: 24915209 [Abstract] [Full Text] [Related]
5. Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study. Martin EM, Russell D, Rubin Z, Humphries R, Grogan TR, Elashoff D, Uslan DZ. Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1323-1330. PubMed ID: 27457254 [Abstract] [Full Text] [Related]
7. Vancomycin-resistant enterococcus (VRE) transmission and risk factors in contacts of VRE carriers. Kaki R, Yu Y, O'Neill C, Lee C, Mertz D, Hamilton Health Sciences Infection Prevention and Control Team. Infect Control Hosp Epidemiol; 2014 Jul; 35(7):876-9. PubMed ID: 24915218 [Abstract] [Full Text] [Related]
8. Impact of Discontinuing Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: An Interrupted Time Series Analysis. Bearman G, Abbas S, Masroor N, Sanogo K, Vanhoozer G, Cooper K, Doll M, Stevens MP, Edmond MB. Infect Control Hosp Epidemiol; 2018 Jun; 39(6):676-682. PubMed ID: 29580304 [Abstract] [Full Text] [Related]
9. Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies. Almyroudis NG, Osawa R, Samonis G, Wetzler M, Wang ES, McCarthy PL, Segal BH. Infect Control Hosp Epidemiol; 2016 Apr; 37(4):398-403. PubMed ID: 26750087 [Abstract] [Full Text] [Related]
10. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Lai KK, Kelley AL, Melvin ZS, Belliveau PP, Fontecchio SA. Infect Control Hosp Epidemiol; 1998 Sep; 19(9):647-52. PubMed ID: 9778162 [Abstract] [Full Text] [Related]
12. Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Morgan DJ, Murthy R, Munoz-Price LS, Barnden M, Camins BC, Johnston BL, Rubin Z, Sullivan KV, Shane AL, Dellinger EP, Rupp ME, Bearman G. Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1163-72. PubMed ID: 26138329 [Abstract] [Full Text] [Related]
13. Postdischarge decontamination of MRSA, VRE, and Clostridium difficile isolation rooms using 2 commercially available automated ultraviolet-C-emitting devices. Wong T, Woznow T, Petrie M, Murzello E, Muniak A, Kadora A, Bryce E. Am J Infect Control; 2016 Apr 01; 44(4):416-20. PubMed ID: 26684367 [Abstract] [Full Text] [Related]
15. Environmental Panels as a Proxy for Nursing Facility Patients With Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus Colonization. Cassone M, Mantey J, Perri MB, Gibson K, Lansing B, McNamara S, Patel PK, Cheng VCC, Walters MS, Stone ND, Zervos MJ, Mody L. Clin Infect Dis; 2018 Aug 31; 67(6):861-868. PubMed ID: 29726892 [Abstract] [Full Text] [Related]
16. Control of a hospital-wide vancomycin-resistant Enterococci outbreak. Kurup A, Chlebicki MP, Ling ML, Koh TH, Tan KY, Lee LC, Howe KB. Am J Infect Control; 2008 Apr 31; 36(3):206-11. PubMed ID: 18371517 [Abstract] [Full Text] [Related]
17. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis. Mac S, Fitzpatrick T, Johnstone J, Sander B. Antimicrob Resist Infect Control; 2019 Apr 31; 8():168. PubMed ID: 31687132 [Abstract] [Full Text] [Related]
18. Intervention to reduce transmission of resistant bacteria in intensive care. Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA, STAR*ICU Trial Investigators. N Engl J Med; 2011 Apr 14; 364(15):1407-18. PubMed ID: 21488763 [Abstract] [Full Text] [Related]